The microbiome-restorative potential of ibezapolstat for the treatment of Clostridioides difficile infection is predicted through variant PolC-type DNA polymerase III in Lachnospiraceae and Oscillospiraceae.

ibezapolstat (ACX-362E) - Acurx Pharma

http://www.ncbi.nlm.nih.gov/pubmed/39982073

Ashok Kumar; Jacob K McPherson; Julian G Hurdle; Kevin W Garey; Matthew L Baker; Tahir Hussain

Feb 21, 2025